BEXIMCO PHARMA.GDR REGS 1 Capital Reinvestment Ratio
BEXIMCO PHARMA.GDR REGS 1 capital reinvestment ratio. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Capital Reinvestment Ratio of 0.27x as of June 2024, meaning it reinvests 0% of its operating cash flow (€8.36 Billion) in capital expenditures (€2.23 Billion). Check BEXIMCO PHARMA.GDR REGS 1 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Capital reinvestment ratio of BEXIMCO PHARMA.GDR REGS 1 from 2022 to 2024. This chart tracks BEXIMCO PHARMA.GDR REGS 1's Capital Reinvestment Ratio across 3 annual periods. Also explore R2WA net asset momentum to track the company's year-over-year net asset growth rate.
BEXIMCO PHARMA.GDR REGS 1 Capital Reinvestment Ratio by Year (2022–2024)
BEXIMCO PHARMA.GDR REGS 1 capital reinvestment ratio by year from 2022 to 2024. For the full cash flow conversion analysis, see BEXIMCO PHARMA.GDR REGS 1 (R2WA) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | €8.36 Billion | €2.23 Billion | ▼ -40.0% |
| 2023 | 0.45x | €6.08 Billion | €2.71 Billion | ▼ -21.0% |
| 2022 | 0.56x | €5.21 Billion | €2.94 Billion | — |